1,665 results on '"Nephrogenic Systemic Fibrosis"'
Search Results
2. Chemical Mechanism of Nephrogenic Systemic Fibrosis and Its Inhibition with Double Chelation.
3. Gadolinium-Based Contrast Agents
4. MRI Safety
5. Occupational Medicine and Toxicology
6. Renal Failure
7. Alone on a collagen island: Unique findings of osseous sclerotic bodies in nephrogenic systemic fibrosis
8. Nodular and diffuse spindle cell infiltration in keloidal scleroderma: a case report
9. The need for prophylactic hemodialysis to protect against nephrogenic systemic fibrosis in patients with end-stage renal disease receiving gadolinium-based contrast agents.
10. Systemic Disease and the Skin
11. Gadolinium-Based Contrast Agents
12. Contrast Reactions
13. Use of Iodinated and Gadolinium-Containing Contrast Media in CKD
14. Safety profile of Gadoterate meglumine on the renal function of patients with severe kidney disease.
15. Magnets, Magnetism, and Magnetic Resonance Imaging: History, Basics, Clinical Aspects, and Future Directions
16. Gadolinium-Based Contrast Agent Toxicity and Accumulation
17. Role of Radiological Assessment and Intervention in Pediatric Dialysis
18. NSF: Real or Hype?
19. Contrast Media
20. Neuro-Ophthalmology Approach to Oculoplastic Disorders
21. Nephrogenic Systemic Fibrosis in Patients with Chronic Kidney Disease after the Use of Gadolinium-Based Contrast Agents: A Review for the Cardiovascular Imager.
22. Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus
23. Update on Gadolinium-Based Contrast Agent Safety, From the AJR Special Series on Contrast Media.
24. Postoperative Decreased Urine Output
25. Gadolinium in Medical Imaging—Usefulness, Toxic Reactions and Possible Countermeasures—A Review.
26. Boosting Vascular Imaging‐Performance and Systemic Biosafety of Ultra‐Small NaGdF4 Nanoparticles via Surface Engineering with Rationally Designed Novel Hydrophilic Block Co‐Polymer.
27. Risk of nephrogenic systemic fibrosis (NSF) in oncology patients receiving gadoxetic acid and updated risk of estimate of NSF in patients receiving gadoxetic acid with moderate and severe renal impairment.
28. Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.
29. Long-term safety of Gadofosveset in clinical practice.
30. Gadolinium retention: should pediatric radiologists be concerned, and how to frame conversations with families.
31. Contrast Agents in Cardiovascular Magnetic Resonance Imaging
32. MR and CT Techniques
33. Case Reports and Case Series
34. Neuroimaging of Post-treatment and Iatrogenic Conditions Related to the Skin and Subcutaneous Tissues
35. Gadolinium deposition disease (GDD): Does the missing link exist? -A suggested pathologic model.
36. Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection (SHERLOC)
37. Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis (GENESYF)
38. Risk of nephrogenic systemic fibrosis in patients with impaired renal function undergoing fixed-dose gadoxetic acid-enhanced magnetic resonance imaging.
39. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium‐based contrast agents
40. Normal Imaging
41. Nephrogenic Systemic Fibrosis in Patients with Chronic Kidney Disease after the Use of Gadolinium-Based Contrast Agents: A Review for the Cardiovascular Imager
42. Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T1 relaxivities at higher magnetic field strength and pH sensing.
43. Safety issues related to intravenous contrast agent use in magnetic resonance imaging.
44. Systemic Sclerosis: The Role of YAP/TAZ in Disease Pathogenesis
45. Gadolinium in Medical Imaging—Usefulness, Toxic Reactions and Possible Countermeasures—A Review
46. MRI Applications: Classification According to Their Biodistribution
47. The Pathology of Systemic Fibroinflammatory Disorders
48. Gadolinium-Induced Fibrosis
49. Cutaneous Fibrosis and Normal Wound Healing
50. Occupational Medicine and Toxicology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.